Cargando…
Mobilization and collection of CD34(+) cells for autologous transplantation of peripheral blood hematopoietic progenitor cells in children: analysis of two different granulocyte-colony stimulating factor doses
INTRODUCTION: The use of peripheral hematopoietic progenitor cells (HPCs) is the cell choice in autologous transplantation. The classic dose of granulocyte-colony stimulating factor (G-CSF) for mobilization is a single daily dose of 10 μg/kg of patient body weight. There is a theory that higher dose...
Autores principales: | Eid, Kátia Aparecida de Brito, Miranda, Eliana Cristina Martins, Aguiar, Simone dos Santos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459484/ https://www.ncbi.nlm.nih.gov/pubmed/26041417 http://dx.doi.org/10.1016/j.bjhh.2015.02.006 |
Ejemplares similares
-
Mobilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience
por: Gabús, Raul, et al.
Publicado: (2011) -
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Eplin, Dwight D., et al.
Publicado: (2019) -
Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma
por: Cox, J E, et al.
Publicado: (2014) -
The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor
por: Girbl, Tamara, et al.
Publicado: (2014) -
Granulocyte‐colony‐stimulating Factor Enhances the Circulating Hematopoietic Progenitors in Lung Cancer Patients Treated with Cisplatin‐containing Regimens
por: Mukai, Jun‐nosuke, et al.
Publicado: (1992)